Oxford Biodynamics Plc:医療機器:M&Aディール及び事業提携情報

【英語タイトル】Oxford Biodynamics Plc - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10447)・商品コード:DATA904C10447
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:44
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company’s products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, Oxfordshire, the UK.

Oxford Biodynamics Plc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Oxford Biodynamics Plc, Medical Equipment, Deal Details 11
Private Equity 11
GL Capital Invests USD12.5 Million in Oxford BioDynamics 11
Partnerships 13
Nova Satra Enters into Licensing Agreement with Oxford BioDynamics 13
Oxford BioDynamics Enters into Agreement with Casa Sollievo della Sofferenza 14
Oxford Biodynamics Enters into Agreement with Holos Life Sciences 15
Oxford Biodynamics Enters Into Agreement With University of Glasgow For Epigenetic Biomarkers 16
Equity Offering 17
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 17
Oxford Biodynamics Plc – Key Competitors 18
Oxford Biodynamics Plc – Key Employees 19
Oxford Biodynamics Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Nov 12, 2018: Oxford BioDynamics forms new alliance to identify autism biomarkers 21
Financial Announcements 22
May 22, 2018: Oxford Biodynamics: Interim Results For The Six-Month Period Ended 31 March 2018 22
Jun 13, 2017: Oxford Biodynamics Interim Results For The Six-Month Period Ended 31 March 2017 23
Jan 31, 2017: Oxford BioDynamics Announces Final Results for the Year Ended 30 September 2016 28
Corporate Communications 30
Sep 15, 2017: Oxford BioDynamics appoints Paul Stockdale as Chief Financial Officer and Executive Director on the Board 30
Jun 30, 2017: Oxford BioDynamics: Appointment of Paul Stockdale as Chief Financial Officer 31
Mar 09, 2017: Oxford BioDynamics announces appointment of Martin Reeves as Senior Vice President of Commercial Development 32
Feb 13, 2017: Oxford BioDynamics appoints Dr Claudio Carini as an Advisor 33
Product News 34
Jul 19, 2018: Oxford BioDynamics announces grant of Canadian patent for its proprietary technology platform, EpiSwitch 34
Feb 14, 2018: Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch 35
Nov 15, 2017: Oxford BioDynamics presents latest immunotherapy data at the NIH Biomarker Consortium Cancer Steering Committee Annual Symposium, in Washington, DC 36
Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 37
Oct 11, 2017: Oxford BioDynamics presents ALS signatures at NEALS 38
Oct 03, 2017: Oxford BioDynamics announces grant of US patent for its proprietary technology platform, EpiSwitch 39
May 31, 2017: Nature (Scientific Reports) publication highlights advantages of EpiSwitch technology platform 40
Other Significant Developments 41
May 23, 2017: Oxford BioDynamics enters into development agreement with two top 10 global pharmaceutical companies 41
Jan 23, 2017: Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch 42
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Oxford Biodynamics Plc, Medical Equipment, Key Facts 2
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Deals By Market, 2012 to YTD 2018 9
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
GL Capital Invests USD12.5 Million in Oxford BioDynamics 11
Nova Satra Enters into Licensing Agreement with Oxford BioDynamics 13
Oxford BioDynamics Enters into Agreement with Casa Sollievo della Sofferenza 14
Oxford Biodynamics Enters into Agreement with Holos Life Sciences 15
Oxford Biodynamics Enters Into Agreement With University of Glasgow For Epigenetic Biomarkers 16
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 17
Oxford Biodynamics Plc, Key Competitors 18
Oxford Biodynamics Plc, Key Employees 19
Oxford Biodynamics Plc, Other Locations 20

List of Figures
Oxford Biodynamics Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[Oxford Biodynamics Plc:医療機器:M&Aディール及び事業提携情報] (コード:DATA904C10447)販売に関する免責事項を必ずご確認ください。
★調査レポート[Oxford Biodynamics Plc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆